Ormel, J, Petukhova, M, Chatterji, S, Aguilar-Gaxiola, S, Alonso, J, Angermeyer, MC, et al.
Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry
2008; 192: 368–75.
Doherty, JL, Owen, MJ.
Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med
2014; 6: 29.
Simonoff, E, Pickles, A, Charman, T, Chandler, S, Loucas, T, Baird, G.
Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry
2008; 47: 921–9.
Lichtenstein, P, Yip, BH, Björk, C, Pawitan, Y, Cannon, TD, Sullivan, PF, et al.
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet
2009; 373: 234–9.
Franke, B, Faraone, SV, Asherson, P, Buitelaar, J, Bau, CHD, Ramos-Quiroga, JA, et al.
The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry
2012; 17: 960–87.
Cardno, AG, Marshall, EJ, Coid, B, Macdonald, AM, Ribchester, TR, Davies, NJ, et al.
Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry
1999; 56: 162–8.
Sullivan, PF, Daly, MJ, O'Donovan, M.
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet
2012; 13: 537–51.
Guilmatre, A, Dubourg, C, Mosca, A-L, Legallic, S, Goldenberg, A, Drouin-Garraud, V, et al.
Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry
2009; 66: 947–56.
Crespi, B, Stead, P, Elliot, M.
Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA
2010; 107 (suppl): 1736–41.
Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet
2013; 381: 1371–9.
Lee, SH, Ripke, S, Neale, BM, Faraone, S V, Purcell, SM, Perlis, RH, et al.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet
2013; 45: 984–94.
Du, P, Kibbe, WA, Lin, SM.
lumi: a pipeline for processing Illumina microarray. Bioinformatics
2008; 24: 1547–8.
Leek, JT, Johnson, WE, Parker, HS, Jaffe, AE, Storey, JD.
The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics
2012; 28: 882–3.
Gaujoux, R, Seoighe, C.
CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics
2013; 29: 2211–2.
Langfelder, P, Horvath, S.
WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics
2008; 9: 559.
Zhang, B, Horvath, S.
A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol
2005; 4: article17.
Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol
2004; 3: article3.
Kelder, T, van Iersel, MP, Hanspers, K, Kutmon, M, Conklin, BR, Evelo, CT, et al.
WikiPathways: building research communities on biological pathways. Nucleic Acids Res
2012; 40: D1301–7.
Lamb, J, Crawford, ED, Peck, D, Modell, JW, Blat, IC, Wrobel, MJ, et al.
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science
2006; 313: 1929–35.
Zerbo, O, Leong, A, Barcellos, L, Bernal, P, Fireman, B, Croen, LA.
Immune mediated conditions in autism spectrum disorders. Brain Behav Immun
2015; 46: 232–6.
Michel, M, Schmidt, MJ, Mirnics, K.
Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol
2012; 72: 1277–87.
Franke, B, Neale, BM, Faraone, SV.
Genome-wide association studies in ADHD.Hum Genet
2009; 126: 13–50.
Cohen-Woods, S, Craig, IW, McGuffin, P.
The current state of play on the molecular genetics of depression. Psychol Med
2013; 43: 673–87.
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J.
An inventory for measuring depression. Arch Gen Psychiatry
1961; 4: 561–71.
Yan, X, Pan, J, Xiong, W, Cheng, M, Sun, Y, Zhang, S, et al.
Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus. Sci China Life Sci
2014; 57: 128–36.
Lee, J-H, You, J, Dobrota, E, Skalnik, DG.
Identification and characterization of a novel human PP1 phosphatase complex. J Biol Chem
2010; 285: 24466–76.
Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci
2015; 18: 199–209.
Dalton, VS, Kolshus, E, McLoughlin, DM.
Epigenetics and depression: return of the repressed. J Affect Disord
2014; 155: 1–12.
Fass, DM, Schroeder, FA, Perlis, RH, Haggarty, SJ.
Epigenetic mechanisms in mood disorders: targeting neuroplasticity. Neuroscience
2014; 264: 112–30.
Gupta-Rossi, N, Ortica, S, Meas-Yedid, V, Heuss, S, Moretti, J, Olivo-Marin, J-C, et al.
The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway. J Biol Chem
2011; 286: 18720–30.
Ables, JL, Breunig, JJ, Eisch, AJ, Rakic, P.
Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci
2011; 12: 269–83.
Glessner, JT, Hakonarson, H.
Common variants in polygenic schizophrenia. Genome Biol
2009; 10: 236.
Yuan, JS, Kousis, PC, Suliman, S, Visan, I, Guidos, CJ.
Functions of notch signaling in the immune system: consensus and controversies. Annu Rev Immunol
2010; 28: 343–65.
Raison, CL, Miller, AH.
Is depression an inflammatory disorder? Curr Psychiatry Rep
2011; 13: 467–75.
Powell, TR, McGuffin, P, D'Souza, UM, Cohen-Woods, S, Hosang, GM, Martin, C, et al.
Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One
2014; 9: e91076.
Haase, J, Brown, E.
Integrating the monoamine, neurotrophin and cytokine hypotheses of depression – a central role for the serotonin transporter? Pharmacol Ther
2015; 147: 1–11.
Miller, AH, Maletic, V, Raison, CL.
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry
2009; 65: 732–41.
Martin, C, Tansey, KE, Schalkwyk, LC, Powell, TR.
The inflammatory cytokines?: molecular biomarkers for major depressive disorder? Biomark Med
2015; 9: 169–80.
Uher, R, Perroud, N, Ng, MY, Hauser, J, Henigsberg, N, Maier, W, et al.
Genomewide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry
2010; 167: 555–64.
Uher, R, Carver, S, Power, RA, Mors, O, Maier, W, Rietschel, M, et al.
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder. Psychol Med
2012; 42: 2027–35.
Köhler, O, Benros, ME, Nordentoft, M, Farkouh, ME, Iyengar, RL, Mors, O, et al.
Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects. JAMA Psychiatry
2014; 71: 1381–91.
Meinzer, MC, Lewinsohn, PM, Pettit, JW, Seeley, JR, Gau, JM, Chronis-Tuscano, A, et al.
Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood. Depress Anxiety
2013; 30: 546–53.
Beineke, P, Fitch, K, Tao, H, Elashoff, MR, Rosenberg, S, Kraus, WE, et al.
A whole blood gene expression-based signature for smoking status. BMC Med Genomics
2012; 5: 58.
Coghlan, S, Horder, J, Inkster, B, Mendez, MA, Murphy, DG, Nutt, DJ.
GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev
2012; 36: 2044–55.